Vascular endothelial growth factor C936T polymorphism in cancer patients with thrombosis [2]

American Journal of Hematology

Volumn 82, Issue 2, 2007, Pages 174-

  Eroglu, Aydan ^a   Gulec, Sukru ^b   Akar, Nejat ^b  

^a Numune State Hospital   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; VASCULOTROPIN;

CANCER PATIENT; COLOR ULTRASOUND FLOWMETRY; DEEP VEIN THROMBOSIS; DNA ISOLATION; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LETTER; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOEMBOLISM; THROMBOSIS;

FEMALE; HUMANS; MALE; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; THROMBOEMBOLISM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENOUS THROMBOSIS;

EID: 33846557930     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20719     Document Type: Letter

References (5)

1. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet 2001;109:369-384.
2. Eroglu A, Kurtman C, Ulu A, Cam R, Akar N. Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis. J Throm Haemost 2005;3:1323-1324.
3. Pinedo HM. The role of VEGF in oncology. Effects on hemostasis and thrombosis. Pathophysiol Haemost Thromb 2003;33:11.12.
4. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999;60:1245-1249.
5. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-448.